Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial
Open Access
- 1 January 2027
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Abstract
Chen L, et al. J Gynecol Oncol. 2027 ;38:e1. https://doi.org/10.3802/jgo.2027.38.e1Keywords
Funding Information
- Noncommunicable Chronic Disease-National Science and Technology Major Project (2025ZD0544103)
- National Natural Science Foundation of China (82103200)
- Natural Science Foundation of Zhejiang Province (LQ22H160033)
This publication has 15 references indexed in Scilit:
- Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II studySignal Transduction and Targeted Therapy, 2025
- Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaThe Lancet, 2024
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trialThe Lancet, 2024
- Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trialThe Lancet Oncology, 2023
- Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung CancerJAMA Oncology, 2023
- The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC)Gynecologic Oncology, 2023
- Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerNew England Journal of Medicine, 2021
- Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging GuidelinesObstetrics & Gynecology, 2019
- Revised FIGO staging for carcinoma of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2019
- Lymph node assessment in cervical cancer: Prognostic and therapeutic implicationsJournal of Surgical Oncology, 2008